Rebecca Araujo

Urban Health Today

A study published in the <a href="https://onlinelibrary.wiley.com/doi/10.1111/ejh.13615">European Journal of Haematology</a> calculated costs and survival outcomes associated with implementation of new early-line treatments for multiple myeloma (MM).For this study, researchers utilized data from the Danish National Health Registers to identify 3,518 patients diagnosed with MM between 2002-2005 or 2010-2013. Participants were randomly matched to controls to compare health care utilization and <a href="https://www.docwirenews.com/urban-health-today/urban-health-multiple-myeloma-knowledge-hub/urban-health-multiple-myeloma-picks/economic-burden-of-late-stage-multiple-myeloma-treatment/">costs</a>.Over the analysis period, health care utilization showed a marked increase in outpatient admissions compared to inpatient admissions. In patients aged &lt; 65 years, outpatient visits increased by 22% between 2002-2005 and 2010-2013, and increased by 28% in patients aged older than 65 years.Mean annual outpatient costs also increased, from &euro;17,001 to &euro;23,643 and &euro;11,317 to &euro;16,144 in younger and older patients, respectively. Fewer inpatient visits translated to lower mean inpatient costs. Total mean costs by younger patients also decreased over time, possibly due in part to fewer MM complications, according to the study authors. Five-year survival improved across both age groups over time.In conclusion, the researchers wrote, &ldquo;Despite the introduction of new expensive early-line MM treatments in 2009, health care costs remained stable due to a shift in health care utilization towards outpatient clinic care and fewer complications.&rdquo;

Lou Portero

Hidden Dangers: The Blood Sugar Crisis in Modern Breast Cancer Treatment

Diabetes in Women

New ACG Guidelines Address Critical Gastric Cancer Disparities in Non-White Americans

Gastroenterology

Ultra-Processed Foods Linked to Increased Ovarian and Breast Cancer Risk

Gynecologic Cancer

Latest News

How Have Improvements in Myeloma Care Impacted Costs?

Multiple Myeloma

A study published in the European Journal of Haematology calculated costs and survival outcomes associated with ...

About Us

Editorial Policy

Contributors & Partners

Contact Us

eNewsletters

Work With Us

Advertising

Career Center

GU Oncology Now

Blood Cancers Today

Cancer Nursing Today

DocWire News

MashupMD

Food Allergy Roundtable Discussions

Allergy

Blood Cancers

— Multiple Myeloma

Breast Cancer

Colorectal Cancer

Pancreatic Cancer

Prostate Cancer

Cancer

Diabetes

Heart Failure

Heart Disease Prevention

Heart Health

— Alzheimer’s Disease

Neurology

Public Health

Autoimmune Disease

Infectious Diseases

Obesity

Pediatrics

Sickle Cell Disease

Digital Health

Dermatology

Pulmonology

Video Insights

Workforce News

More

Heart Disease in Women

Menopause

Reproductive Health

Women’s Neurology

Well Woman Today

Roundtables

Podcasts

Conferences

Viewpoints

Subscribe